Hi guys,
Foamix Pharmaceuticals Ltd. (Nasdaq: FOMX), a clinical stage specialty pharmaceutical company focused on developing and commercializing proprietary topical therapies to address unmet needs in dermatology
Foamix Pharmaceuticals Ltd. (Nasdaq: FOMX), a clinical stage specialty pharmaceutical company focused on developing and commercializing proprietary topical therapies to address unmet needs in dermatology
- An NDA for FMX101 to treat acne vulgaris was filed with the FDA.
- A PDUFA date has been established for October 20, 2019.
Long:
- LMT 1- 3.15$ (20 % of the planned investment amount)
- LMT 2- 2.89$ (40 % of the planned investment amount)
- LMT 3- 2.78$ (40 % of the planned investment amount)
TP:7$
Comments and likes are greatly appreciated.
I/we have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions and this is not a call for investment. I am not receiving compensation for it . I have no business relationship with any company whose stock is mentioned in this article.